Skip to main content
Premium Trial:

Request an Annual Quote

Newsham Genetics To Acquire Monsanto Genomics Unit

NEW YORK (GenomeWeb News) - Newsham Genetics said yesterday that it has signed a definitive agreement to purchase Monsanto Choice Genetics, a subsidiary of the agricultural giant.
The transaction will be completed “as soon as practical,” Newsham said.
In a statement, Newsham said it “placed high value on the significant investment made by MCG over the past 10 years in their genomics platform.”
Newsham’s Co-CEO Mike Weaver noted that MCG has developed “the most extensive swine genomic map in the industry, with over 6,000 genomic marker associations for swine performance,” which is expected to help Newsham to “accelerate genetic progress across many different traits for the industry."
According to Newsham’s Co-CEO Brent Mitchell, MCG and Newsham are currently the second and third largest swine genetics companies, respectively. The acquisition, he said, “will create a very strong and vibrant player in the North American market with the most extensive technology in the industry.”
As part of the agreement, the companies have entered a three-year research alliance that will focus on the MCG genomics platform “to maximize the value created in the industry from these tools.”

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.